BACKGROUND Cardiovascular disease among hemodialysis (HD) patients is linked to poor outcomes. The Acute
community-based outpatient HD facilities as previously described (11, 12) . This study included ECHOCARDIOGRAPHY. ECHOs performed #1 month prior to or #3 months after dialysis initiation were identified through the Mayo Clinic Echocardiographic Laboratory database. Indications for ECHO are included in Online Table 1 . ECHO was performed according to ASE and EAE guidelines for assessment of valves and chamber size and function (7) (8) (9) (10) . SHD was defined according to the proposed criteria from the ADQI XI Workgroup (6), except for left ventricular (LV) regional wall motion abnormalities (RWMA). The 16-segment model was used for RWMA assessment, and any RWMA was included (instead of >10% of the myocardium); and right ventricular (RV) systolic dysfunction included semiquantitative assessment. 56%, respectively, p < 0.001), and Charlson score $8 (45% vs. 52%, respectively, p ¼ 0.02) but were more likely to have an AV fistula or graft dialysis access present at first dialysis treatment (39% vs. 20%, respectively, p < 0.001) (Online Table 2 ). Overall survival also differed between groups ( Figure 1A ). ECHO FINDINGS AND SHD. Baseline ECHO findings among patients with SHD are shown in Table 2 .
Study patients who underwent
Median time between ECHO and HD initiation was 0 days (IQR: À4 to 8 days). Most patients (85%) had (2%) were transitioned to home HD or PD, and 96 (40%) were alive at the end of the study. Overall, 415 patients died; 108 (26%) of these deaths occurred within 6 months. Cumulative death rates were 17%, (29) 17 (20) 175 (31) Hypertension 100 (19) 99 (15) 11 (13) 88 (16) Glomerulonephritis/tubulointerstitial nephritis 73 (14) 79 (12) 13 (15) 66 (12) Polycystic kidney disease 15 (3) 12 (2) 1 (1) 11 (2) Refractory acute tubular necrosis 9 (2) 54 (8) 9 (10) 43 (8) Failing kidney transplant 35 (7) 38 (6) 11 (13) 27 (5) Other/unknown 104 (20) 182 (28) 25 (29) 157 (28) First dialysis access used 
DISCUSSION
In our study cohort, SHD was common, with a substantial majority of the patients having $1 baseline ECHO abnormality and more than one-half having $3. LEFT VENTRICLE AND MORTALITY. Several studies have shown impaired LVEF, diastolic dysfunction, and LVH as predictors of mortality in dialysis patients (17) (18) (19) (20) (21) (22) (23) (24) (25) . Yamada et al. (23) found that, in 1,254 incident HD patients of similar age to those in the present study (62 AE 14 years) and who were followed for 7 years, reduced LVEF was present in 13% and was a strong predictor of death from cardiovascular events as well as all-cause mortality. Progressive decline of LVEF was associated with increasing risk of death. We also found LV dysfunction was prevalent and associated with higher risk of mortality.
Diastolic dysfunction of grade 2 or higher was not independently associated with excess mortality in the age-and sex-adjusted analyses of our entire study cohort. However, an association with diastolic dysfunction and mortality was seen in patients who initiated dialysis before an ECHO was performed. (range: 29 to 79 years of age) who were on HD therapy for at least 6 months and followed for more than 10 years. Our study confirmed the link between impaired LV systolic function but not LVH or diastolic dysfunction and poor outcome.
RIGHT VENTRICLE AND MORTALITY. In this study, RV systolic dysfunction was relatively common (27%), and a minority of patients (10%) had moderate to severe dysfunction. RV systolic dysfunction was independently associated with poor survival even when modeled with age, sex, diabetes, ESRD cause, and AV fistula access in a multivariate analysis. RV dysfunction in HD patients is thought to result from chronic volume overload and is exacerbated by AV fistula access, especially in the brachial position (27, 28) . RV dysfunction in turn leads to an impaired LV. This was shown by Paneni et al. (27) those who had an ECHO and those that did not.
Our study nonetheless provides insight into the need for a standardized approach to SHD assessment, 
